We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

RNA Sequencing of Nasal Samples Used to Diagnose Asthma

By LabMedica International staff writers
Posted on 25 Jun 2018
Print article
Image: Peak flow meters, used to measure the peak expiratory flow rate in both monitoring and diagnosing asthma (Photo courtesy of Wikimedia Commons).
Image: Peak flow meters, used to measure the peak expiratory flow rate in both monitoring and diagnosing asthma (Photo courtesy of Wikimedia Commons).
A 90-gene biomarker panel has been established that enables the rapid, accurate diagnosis of asthma from simple nasal brush samples.

A nasal biomarker of asthma is of high interest given the accessibility of the nose and shared airway biology between the upper and lower respiratory tracts. The easily accessible nasal passages are directly connected to the lungs and exposed to common environmental factors.

In this regard, investigators at the Icahn School of Medicine at Mount Sinai (New York, NY, USA) sought to identify a nasal brush-based classifier of mild/moderate asthma. For this study, 190 subjects with mild/moderate asthma and controls underwent nasal brushing and RNA sequencing of the nasal samples.

The investigators used RNA sequencing (RNAseq) to comprehensively profile gene expression from nasal brushings collected from subjects with mild to moderate asthma and controls, creating the largest nasal RNAseq data set in asthma to date. They focused on mild to moderate asthma because the waxing and waning nature of non-severe asthma render it relatively difficult to diagnose.

Using a robust machine learning-based pipeline comprised of feature selection, classification, and statistical analyses, the investigators identified a 90-gene asthma classifier that accurately differentiated between subjects with and without mild-moderate asthma based on nasal brushings. They evaluated the classification performance of this asthma classifier on eight test sets of independent subjects with asthma and other respiratory conditions, finding that it performed with high accuracy, sensitivity, and specificity for asthma.

“Mild to moderate asthma can be difficult to diagnose because symptoms change over time and can be complicated by other respiratory conditions,” said senior author Dr. Supinda Bunyavanich, a physician and researcher at the Icahn School of Medicine at Mount Sinai. “Our nasal brush test takes seconds to collect. For time-strapped clinicians, particularly primary care providers at the front lines of asthma diagnosis, this could greatly improve patient outcomes through early and accurate diagnosis. With prospective validation in large cohorts, our asthma biomarker could lead to the development of a minimally invasive test to aid asthma diagnosis at clinical frontlines where time and resources often preclude pulmonary function testing.”

The asthma biomarker study was published in the June 11, 2018, online edition of the journal Scientific Reports.

Related Links:
Icahn School of Medicine at Mount Sinai

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.